Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHLOROQUINE PHOSPHATE AGAINST INFECTION BY SARS-CoV-2 (COVID-19): HOPE Trial
2020-001345-38Phase 2Completed
- Sponsor
- Uni-Pharma
- Start
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of chloroquine in coronavirus disease 2019 (COVID-19) and pneumonia, sponsored by Uni-Pharma. Primary endpoint: Primary: Clinical and laboratory parameter assessment by day 8. Started Mar 2020; status: completed.
02
Drugs
chloroquine
03
Conditions
coronavirus disease 2019 (COVID-19)pneumonia
Beyond the preview
Go deeper on 2020-001345-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001345-38.